Excessive glucocorticoids combined with RANKL promote the differentiation of bone marrow macrophages (BMM) into osteoclasts and accelerate the progression of osteoporosis by activating the SYK/SHP2/NF-κB signaling pathway
Aging · 2024
DOI: 10.18632/aging.206084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Hao Dong und 5 weiteren Autor:innen. Beteiligte Einrichtung: West Campus of Zibo Central Hospital, Zibo, Shandong, China. Hauptthemen laut MEDLINE: RANK Ligand, Osteoclasts, Cell Differentiation, Signal Transduction. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- West Campus of Zibo Central Hospital, Zibo, Shandong, China.
- Zibo Central Hospital, Zibo, Shandong, China.
Zitieren
APA
Dong, H., Liu, X., Duan, J., Zhang, J., Liu, H., & Shen, T. (2024). Excessive glucocorticoids combined with RANKL promote the differentiation of bone marrow macrophages (BMM) into osteoclasts and accelerate the progression of osteoporosis by activating the SYK/SHP2/NF-κB signaling pathway. Aging. https://doi.org/10.18632/aging.206084
Vancouver
Dong H, Liu X, Duan J, Zhang J, Liu H, Shen T. Excessive glucocorticoids combined with RANKL promote the differentiation of bone marrow macrophages (BMM) into osteoclasts and accelerate the progression of osteoporosis by activating the SYK/SHP2/NF-κB signaling pathway. Aging. 2024. doi:10.18632/aging.206084
BibTeX
@article{Dong2024,
author = {Dong, Hao and Liu, Xiaocong and Duan, Jiqiang and Zhang, Jing and Liu, Hao and Shen, Tiehui},
title = {Excessive glucocorticoids combined with RANKL promote the differentiation of bone marrow macrophages (BMM) into osteoclasts and accelerate the progression of osteoporosis by activating the SYK/SHP2/NF-κB signaling pathway},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.206084}
}
EUVIMED